TrialNature communications2026

Efficacy and safety of low-dose interleukin 2 for Behçet's syndrome: a randomized, placebo-controlled, double-blind, phase 2 clinical trial.

Tian Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.